LANNI, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 8.865
AS - Asia 5.586
EU - Europa 5.074
SA - Sud America 744
Continente sconosciuto - Info sul continente non disponibili 282
AF - Africa 166
OC - Oceania 19
Totale 20.736
Nazione #
US - Stati Uniti d'America 8.515
CN - Cina 2.791
SG - Singapore 1.222
IE - Irlanda 1.174
UA - Ucraina 706
IT - Italia 615
DE - Germania 598
HK - Hong Kong 585
BR - Brasile 548
FI - Finlandia 533
RU - Federazione Russa 489
VN - Vietnam 414
FR - Francia 352
GB - Regno Unito 244
SE - Svezia 168
CA - Canada 136
IN - India 130
ZA - Sudafrica 80
BD - Bangladesh 76
AR - Argentina 75
JP - Giappone 53
MX - Messico 45
NL - Olanda 35
PK - Pakistan 34
EC - Ecuador 31
ID - Indonesia 30
CR - Costa Rica 29
IQ - Iraq 29
CO - Colombia 27
TR - Turchia 27
ES - Italia 26
HN - Honduras 24
IL - Israele 24
PL - Polonia 23
BE - Belgio 20
SV - El Salvador 20
TT - Trinidad e Tobago 20
SA - Arabia Saudita 19
VE - Venezuela 19
MY - Malesia 17
GT - Guatemala 16
PH - Filippine 16
UZ - Uzbekistan 16
AT - Austria 15
CW - ???statistics.table.value.countryCode.CW??? 14
JM - Giamaica 14
TN - Tunisia 14
NZ - Nuova Zelanda 13
PR - Porto Rico 13
GP - Guadalupe 12
IR - Iran 12
PE - Perù 12
CZ - Repubblica Ceca 11
PY - Paraguay 11
SC - Seychelles 11
AZ - Azerbaigian 10
CL - Cile 10
JO - Giordania 10
NI - Nicaragua 10
MA - Marocco 9
NP - Nepal 9
PT - Portogallo 9
DZ - Algeria 8
EG - Egitto 8
KZ - Kazakistan 8
KE - Kenya 7
KR - Corea 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
BO - Bolivia 6
LT - Lituania 6
OM - Oman 6
CH - Svizzera 5
MD - Moldavia 5
MU - Mauritius 5
TH - Thailandia 5
AL - Albania 4
BH - Bahrain 4
CG - Congo 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
LB - Libano 4
RO - Romania 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
XK - ???statistics.table.value.countryCode.XK??? 4
GE - Georgia 3
GR - Grecia 3
HR - Croazia 3
KG - Kirghizistan 3
KW - Kuwait 3
PA - Panama 3
PS - Palestinian Territory 3
AO - Angola 2
BB - Barbados 2
BG - Bulgaria 2
BJ - Benin 2
BY - Bielorussia 2
EE - Estonia 2
Totale 20.435
Città #
Dublin 1.171
Chandler 997
Ashburn 834
Jacksonville 830
San Jose 814
Singapore 639
Nanjing 579
Hong Kong 575
Beijing 446
Council Bluffs 392
Dallas 368
Boardman 311
Nanchang 251
Shenyang 201
Princeton 197
Lawrence 191
Medford 187
Los Angeles 172
Wilmington 167
Lauterbourg 165
Helsinki 160
Jiaxing 144
Hebei 142
Changsha 141
Munich 140
Ho Chi Minh City 130
Pavia 119
Tianjin 114
New York 96
Hangzhou 92
Shanghai 91
Buffalo 88
Hanoi 88
Santa Clara 88
Ann Arbor 85
Milan 80
São Paulo 72
Johannesburg 70
Moscow 70
Redondo Beach 66
Turku 57
Verona 48
Orem 45
Woodbridge 45
Tokyo 44
Toronto 38
Montreal 37
Frankfurt am Main 36
Norwalk 36
Chennai 31
Chicago 31
Houston 30
Brooklyn 28
Falkenstein 26
Phoenix 26
San Francisco 26
Seattle 25
The Dalles 25
London 24
Washington 24
Da Nang 23
Denver 23
Rome 23
San José 23
Boston 22
Guangzhou 21
Manchester 21
Brussels 20
San Salvador 19
Haiphong 18
Rio de Janeiro 18
Stockholm 18
Atlanta 17
Brescia 17
Columbus 17
Des Moines 17
Nuremberg 17
Zhengzhou 17
Pune 16
Tashkent 15
Amsterdam 14
Baghdad 14
Dearborn 14
Dong Ket 14
Mumbai 14
Warsaw 14
Fairfield 13
Florence 13
Guatemala City 13
Jakarta 13
Kunming 13
Willemstad 13
Dhaka 12
Jeddah 12
Jinan 12
North Bergen 12
Palmerston North 12
Tegucigalpa 12
Brasília 11
Belo Horizonte 10
Totale 12.882
Nome #
L'ipotesi della cascata amiloide nella malattia di Alzheimer: studi su strategie di neuroprotezione. 220
A composite nanosystem as a potential tool for the local treatment of glioblastoma: Chitosan‐coated solid lipid nanoparticles embedded in electrospun nanofibers 176
Antiradical Activity of Water solubile Components of Common Diet Vegetables 166
Amyloid beta-Protein (Abeta) Assembly: Abeta 1-40 And Abeta 1-42 different behaviour in the aggregation process 161
Acetylcholinesterase inhibitors: effects on pharmacological regulation of amyloid precursor protein processing 155
Advances in understanding the pathogenetic mechanisms of Alzheimer's disease 155
A novel pathway based on the recruitment of casein kinase 2 is involved in APP processing following cholinergic stimulation. 155
Beta-amyloid short- and long-term synaptic entanglement 154
Anti-hydroxyl radical activity of common edible vegetables 152
Derivati antracenedionici e aza-antracenedionici come agenti capaci di inibire l’aggregazione di peptidi beta amiloidi 148
DNA damage accumulation and efficiency of DNA repair process in Down syndrome cell model systems 147
Characterization of the antioxidant effects of γ-oryzanol: Involvement of the Nrf2 Pathway 144
Proliferation characteristics and polyploidization of cultured myofibroblasts from a patient with fibroblastic rheumatism 143
An integrated strategy to correlate aggregation state, structure and toxicity of Aß 1–42 oligomers 143
COGNITION ENHANCERS BETWEEN TREATING AND DOPING THE MIND 140
Depression and antidepressants: molecular and cellular aspects. 140
Anti-hydroxyl radical activity of common edible vegetables 140
Capillary electrophoresis studies on the aggregation process of beta-amyloid 1-42 and 1-40 peptides 138
Antiradical activity of vegetables commonly included in the mediterranean diet 137
Dopare il cervello 136
Depressione: le nuove ipotesi sulle basi biologiche e il razionale di impiego e sviluppo dei farmaci antidepressivi 135
Acute beta-amyloid administration disrupts the cholinergic control of dopamine release in the nucleus accumbens 134
The expanding universe of neurotrophic factors: therapeutic potential in aging and age-associated disorders. 132
Acetylcholinesterase inhibitors modulate the metabolism of the amyloid precursor protein via different cellular mechanisms. 130
Studies on neuroprotective strategy based on the Amyloid Cascade Hypothesis 129
Acetylcholinesterase inhibitors: novel activities of old molecules 129
Prenylated curcumin analogues as multipotent tools to tackle Alzheimer's disease 128
A novel composite nanosystem as a potential tool for the local treatment of glioblastoma. 127
Appreciation of functional rather than lesional effects of beta amyloid (AB): a study on dopamine release following in vivo AB infusion 126
Beta-amyloid: a disease target or a synaptic regulator affecting age-related neurotransmitter changes? 125
Role of b-amyloid in the pathophysiology of Alzheimer’s disease and cholinesterase inhibition: facing the biological complexity to treat the disease. 125
Emerging aspects of Alzheimer's disease (AD) pharmacotherapy and relationships with the underlying pathogenetic mechanisms 125
(Dys)regulation of Synaptic Activity and Neurotransmitter Release by β-Amyloid: A Look Beyond Alzheimer's Disease Pathogenesis 125
Transizione conformazionale di proteine fibrillari e neurodegenerazione 124
Nicotinic component of galantamine in the regulation of amyloid precursor protein processing 124
Alterazioni vascolari e demenza: considerazioni sui possibili meccanismi biologici 123
Altered DNA damage response in Down syndrome cells 123
Dangerous liaisons between Beta-amyloid and cholinergic neurotransmission” 123
APP processing: some details of downstream cholinergic stimulation. 122
Alzheimer's disease: new diagnostic and therapeutic tools 122
PCK alfa recruitment of neural Elav proteins: implication for mRNA stability and translation 121
Dehydroepiandrosterone and cortisol: effects on GNB2L1 human promoter region coding for RACK-1 scaffold protein. 121
Different Effects of Beta-Amyloid on α7 and α4β2 Nicotinic Receptors Controlling the Release of Aminoacids in Rat Hippocampus 121
Unfolded p53 in blood as a predictive signature signature of the transition from mild cognitive impairment to Alzheimer's disease. 121
Role of spliceosome proteins in the regulation of glucocorticoid receptor isoforms by cortisol and dehydroepiandrosterone 121
Effect of beta-amyloid infusion on dopamine release in limbic and motor dopaminergic areas 119
Presence and passage-dependent loss of biochemical M3-muscarinic receptor function in human detrusor cultured smooth muscle cells 119
Antagonismo dei recettori NMDA: una nuova strategia per la neuroprotezione ed il trattamento delle demenze 119
Antagonismo dei recettori NMDA: una nuova strategia per la neuroprotezione ed il trattamento delle demenze 118
Conformational Altered p53 as an Early Marker of Oxidative Stress in Alzheimer's Disease. 118
Zyxin is a novel target for beta-amyloid peptide: characterization of its role in Alzheimer pathogenesis. 118
Attività antiradicalica del caffè verde e tostato 117
Alternative views on beta amyloid: a disease target or a cell neuromodulator at the edge between signalling and degeneration. 117
beta-Amyloid precursor protein metabolism: focus on the functions and degradation of its intracellular domain. 116
APP intracellular C-terminal domain function is related to its degradation process. 116
Targeting the Nrf2/Amyloid-Beta Liaison in Alzheimer's Disease: A Rational Approach 116
Discovery of Abeta protein fibrillogenesis inhibitors by using CE. 115
Identification of a mutant-like conformation of p53 in fibroblasts from sporadic Alzheimer's disease patients. 115
Wild type but not mutant APP is involved in protective adaptive responses against oxidants. 115
Zyxin is a novel target for beta-amyloid peptide: characterisation of its role in Alzheimer pathogenesis 115
Vegetable extracts protect IMR32 cells against H2O2 induced toxicity 115
Modulation of Keap1/Nrf2/ARE Signaling Pathway by Curcuma- and Garlic-Derived Hybrids 115
Regulation amyloid precursor protein processing: nicotinic component of galantamine 114
Homeodomain interacting protein kinase 2: a target for Alzheimer's beta amyloid leading to misfolded p53 and inappropriate cell survival. 114
Amyloid-β and Synaptic Vesicle Dynamics: A Cacophonic Orchestra. 114
Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2 113
Galantamine: effect on the pharmacological regulation of the amyloid B precursor protein processing 111
Elav-Like Proteins And Protein Kinase C: A New Cascade For Memory Trace Formation And Alzheimer's Disease? 111
Unfolded p53 in the pathogenesis of Alzheimer's disease: is HIPK2 the link? 111
Merging memantine and ferulic acid to probe connections between NMDA receptors, oxidative stress and amyloid-β peptide in Alzheimer's disease 111
Conformational mutant isoform of p53 in blood peripheral cells: a putative marker for Alzheimer's disease 110
Vegetable extracts protect IMR32 cells against H2O2 induced toxicity 110
Modulation of Rack-1/PKCβII signalling by soluble AβPPα in SH-SY5Y cells. 110
Conformational altered p53 affects neuronal function: relevance for the response to toxic insult and growth-associated protein 43 expression 110
In vitro and ex vivo antihydroxyl radical activity of green and dark roasted coffee 109
Capillary electrophoresis separation of metastable intermediates of amyloid protein fibrillogenesis to use them as independent targets for small molecules. 109
Transcriptional regulation of RACK1 and modulation of its expression: Role of steroid hormones and significance in health and aging 109
Cancer and Alzheimer's disease inverse relationship: an age-associated diverging derailment of shared pathways 109
White matter lesions in the elderly: effect on brain plasticity and reserve 108
Opposing effects of cortisol and dehydroepiandrosterone on the expression of the receptor for Activated C Kinase 1: implications in immunosenescence. 108
Immunomodulators inspired by nature: A review on curcumin and Echinacea 107
Nature-inspired Nrf2 activators in retinal pigment epithelial cells: a source for therapeutics in Age-related Macular Degeneration 106
New nature-inspired hybrids targeting the Nrf2-HO1 pathway protect retinal pigment epithelial cells under stress conditions. 106
Role of acetylcholinesterase inhibitors in the pharmacological regulation of amyloid precursor protein processing 105
Beta amyloid infusion impairs dopamine release in the nucleus accumbens. 105
Role of hormones in the regulation of RACK1 expression as a signaling checkpoint in immunosenescence 105
New nature-inspired hybrids activating the Nrf2-HO1 pathway in retinal pigment epithelial cells and their potential use in pathologies featured by oxidative stress 105
Molecular regulations of circadian rhythm and implications for physiology and diseases 104
Galantamina, razionale farmacologico 104
Basi neurobiologiche del ritardo mentale 104
In vitro and ex vivo antihydroxyl radical activity of green and roasted coffee 104
Capillary electrophoresis studies on the aggregation process of abeta 1-42 and abeta 1-40 peptides 104
Culture primarie di muscolatura liscia di vescica come tool farmacologico per lo studio della trasmissione delle vie colinergiche nell'uomo. 103
Targeting Cytokine Release Through the Differential Modulation of Nrf2 and NF-κB Pathways by Electrophilic/Non-Electrophilic Compounds 103
Silk Fibroin Nanoparticle Functionalization with Arg-Gly-Asp cyclopentapeptide Promotes Active Targeting for Tumor Site-Specific Delivery 103
Unfolded p53: a potential biomarker for Alzheimer's disease 102
Disturbi della sfera affettiva e farmaci monoaminergici 102
Galantamina: il farmaco e il contesto 102
Dual effect of beta-amyloid on α7 and α4β2 nicotinic receptors controlling the release of glutamate, aspartate and GABA in rat hippocampus 102
Curcumin in Alzheimer's disease: Can we think to new strategies and perspectives for this molecule? 102
Totale 12.238
Categoria #
all - tutte 84.825
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.825


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022853 0 0 0 0 7 31 8 49 46 10 131 571
2022/20233.050 299 215 23 211 307 323 1 164 1.376 8 89 34
2023/2024995 126 161 40 100 104 224 24 78 9 66 27 36
2024/20252.660 51 248 80 98 42 145 92 214 631 85 310 664
2025/20265.877 478 427 619 654 705 339 1.136 243 493 478 189 116
2026/20272.049 117 303 435 832 362 0 0 0 0 0 0 0
Totale 20.736